Glenmark becomes the First Pharmaceutical Company to launch Zita Plus Pio Drug for Type 2 Diabetes in India
Pune, 25 April 2022: Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of...